Constitutive Expression of Yes-Associated Protein (Yap) in Adult Skeletal Muscle Fibres Induces Muscle Atrophy and Myopathy

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Judson, Robert N ^a   Gray, Stuart R ^a   Walker, Claire ^a   Carroll, Andrew M ^a   Itzstein, Cecile ^a   Lionikas, Arimantas ^a   Zammit, Peter S ^b   De Bari, Cosimo ^a   Wackerhage, Henning ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; MESSENGER RNA; MUSCLE ENZYME; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; MYOSIN HEAVY CHAIN; NICOTINAMIDE ADENINE DINUCLEOTIDE REDUCTASE; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRONUCLEAR MYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GAIT DISORDER; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; IN VIVO STUDY; KYPHOSIS; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE REGENERATION; MYOPATHY; NONHUMAN; PHENOTYPIC VARIATION; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEIGHT REDUCTION; YES ASSOCIATED PROTEIN GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGING; ANIMALS; DOXYCYCLINE; GENE EXPRESSION PROFILING; HUMANS; KYPHOSIS; MICE; MICE, TRANSGENIC; MUSCLE FIBERS, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DISEASES; MUTANT PROTEINS; NECROSIS; ORGAN SPECIFICITY; PHENOTYPE; PHOSPHOPROTEINS; TRANSGENES; UP-REGULATION; WASTING SYNDROME; WEIGHT LOSS;

MUS; MUS MUSCULUS;

EID: 84875468181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059622     Document Type: Article

References (65)

1. Janssen I, Heymsfield SB, Wang ZM, Ross R, (2000) Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 89: 81-88.
2. Heron MI, Richmond FJ, (1993) In-series fiber architecture in long human muscles. J Morphol 216: 35-45.
3. Studitsky AN, (1964) FREE AUTO- AND HOMOGRAFTS OF MUSCLE TISSUE IN EXPERIMENTS ON ANIMALS. Ann N Y Acad Sci 120: 789-801.
4. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, et al. (2005) Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301.
5. Scharner J, Zammit PS, (2011) The muscle satellite cell at 50: the formative years. Skelet Muscle 1: 28.
6. Relaix F, Zammit PS, (2012) Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139: 2845-2856.
7. Philp A, Hamilton DL, Baar K, (2011) Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1. J Appl Physiol 110: 561-568.
8. Schiaffino S, (2010) Fibre types in skeletal muscle: a personal account. Acta Physiol (Oxf) 199: 451-463.
9. Hardie DG, (2011) Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. Proc Nutr Soc 70: 92-99.
10. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
11. Wolfe RR, (2006) The underappreciated role of muscle in health and disease. Am J Clin Nutr 84: 475-482.
12. Zhao B, Tumaneng K, Guan KL, (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13: 877-883.
13. Watt K, Judson R, Medlow P, Reid K, Kurth T, et al. (2010) Yap is a novel regulator of C2C12 myogenesis. Biochem Biophys Res Commun 393: 619-624.
14. Sudol M, Chen HI, Bougeret C, Einbond A, Bork P, (1995) Characterization of a novel protein-binding module-the WW domain. FEBS Lett 369: 67-71.
15. Komuro A, Nagai M, Navin NE, Sudol M, (2003) WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278: 33334-33341.
16. Pan D, (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505.
17. Sudol M, Harvey KF, (2010) Modularity in the Hippo signaling pathway. Trends Biochem Sci 35: 627-633.
18. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. (2011) Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144: 782-795.
19. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, et al. (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332: 458-461.
20. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, et al. (2011) Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018-7026.
21. Zhao B, Li L, Lu Q, Wang LH, Liu CY, et al. (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63.
22. Halder G, Polaczyk P, Kraus ME, Hudson A, Kim J, et al. (1998) The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev 12: 3900-3909.
23. Mahoney WM, Hong JH, Yaffe MB, Farrance IK, (2005) The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 388: 217-225.
24. Mielcarek M, Günther S, Krüger M, Braun T, (2002) VITO-1, a novel vestigial related protein is predominantly expressed in the skeletal muscle lineage. Mech Dev 119Suppl 1: S269-274.
25. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML, (2001) TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15: 1229-1241.
26. Pobbati AV, Chan SW, Lee I, Song H, Hong W, (2012) Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes. Structure 20: 1135-1140.
27. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
28. Harvey K, Tapon N, (2007) The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191.
29. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
30. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
31. von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, et al. (2012) YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A 109: 2394-2399.
32. Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, et al. (2011) Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal 4: ra70.
33. Zhang H, Pasolli HA, Fuchs E, (2011) Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci U S A 108: 2270-2275.
34. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
35. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, et al. (2011) Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A 108: E1312-1320.
36. Ramos A, Camargo FD, (2012) The Hippo signaling pathway and stem cell biology. Trends Cell Biol 22: 339-346.
37. Judson RN, Tremblay AM, Knopp P, White RB, Urcia R, et al. (2012) The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells. J Cell Sci.
38. Carson JA, Schwartz RJ, Booth FW, (1996) SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. Am J Physiol 270: C1624-1633.
39. Tsika RW, Schramm C, Simmer G, Fitzsimons DP, Moss RL, et al. (2008) Overexpression of TEAD-1 in transgenic mouse striated muscles produces a slower skeletal muscle contractile phenotype. J Biol Chem 283: 36154-36167.
40. Grill MA, Bales MA, Fought AN, Rosburg KC, Munger SJ, et al. (2003) Tetracycline-inducible system for regulation of skeletal muscle-specific gene expression in transgenic mice. Transgenic Res 12: 33-43.
41. Nguyen QG, Buskin JN, Himeda CL, Fabre-Suver C, Hauschka SD, (2003) Transgenic and tissue culture analyses of the muscle creatine kinase enhancer Trex control element in skeletal and cardiac muscle indicate differences in gene expression between muscle types. Transgenic Res 12: 337-349.
42. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, et al. (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 97: 9209-9214.
43. Carroll AM, Palmer AA, Lionikas A, (2011) QTL Analysis of Type I and Type IIA Fibers in Soleus Muscle in a Cross between LG/J and SM/J Mouse Strains. Front Genet 2: 99.
44. Vercherat C, Chung TK, Yalcin S, Gulbagci N, Gopinadhan S, et al. (2009) Stra13 regulates oxidative stress mediated skeletal muscle degeneration. Hum Mol Genet 18: 4304-4316.
45. Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, et al. (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117: 889-901.
46. Eghtesad S, Jhunjhunwala S, Little SR, Clemens PR, (2011) Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle. Mol Med 17: 917-924.
47. Hämäläinen N, Pette D, (1993) The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit. J Histochem Cytochem 41: 733-743.
48. Ciciliot S, Schiaffino S, (2010) Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr Pharm Des 16: 906-914.
49. Siegel AJ, Silverman LM, Evans WJ, (1983) Elevated skeletal muscle creatine kinase MB isoenzyme levels in marathon runners. JAMA 250: 2835-2837.
50. Romero NB, Bitoun M, (2011) Centronuclear myopathies. Semin Pediatr Neurol 18: 250-256.
51. Cai D, Frantz JD, Tawa NE, Melendez PA, Oh BC, et al. (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298.
52. Tiao G, Lieberman M, Fischer JE, Hasselgren PO, (1997) Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am J Physiol 272: R849-856.
53. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
54. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, et al. (2009) During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185: 1083-1095.
55. Salah Z, Melino G, Aqeilan RI, (2011) Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res 71: 2010-2020.
56. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL, (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72-85.
57. Zhi X, Zhao D, Zhou Z, Liu R, Chen C, (2012) YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Am J Pathol 180: 2452-2461.
58. White RB, Biérinx AS, Gnocchi VF, Zammit PS, (2010) Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev Biol 10: 21.
59. Morales MG, Cabello-Verrugio C, Santander C, Cabrera D, Goldschmeding R, et al. (2011) CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. J Pathol 225: 490-501.
60. Jungbluth H, Wallgren-Pettersson C, Laporte J, (2008) Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 3: 26.
61. Romero NB, (2010) Centronuclear myopathies: a widening concept. Neuromuscul Disord 20: 223-228.
62. Fujimura-Kiyono C, Racz GZ, Nishino I, (2008) Myotubular/centronuclear myopathy and central core disease. Neurol India 56: 325-332.
63. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13: 175-182.
64. Bitoun M, Maugenre S, Jeannet PY, Lacène E, Ferrer X, et al. (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37: 1207-1209.
65. Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, et al. (2007) Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39: 1134-1139.